To include your compound in the COVID-19 Resource Center, submit it here.

AstraZeneca denies Crestor rumors

AstraZeneca (AZN; LSE:AZN) denied rumors that FDA requested that the company start new trials

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE